home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Gene Therapy Development & Manufacturing 2023

  January 16, 2023  
Oxford Global, Congress Centre, 28 Great Russell Street, London, WC1B 3LS
2023-06-13 -2023-06-14

Day One
Vector Development
  • Viral & non-viral vector safety & quality 
  • Delivery and dosage challenges for gene therapies 
  • Effective testing, characterisation & validation approaches 
Gene Therapy Manufacturing
  • Scalable and cost-effective production processes 
  • Balancing speed-to-market and product quality 
  • Internal vs external manufacturing 
Pre-Clinical & Clinical Gene Therapy
  • CAR-T, TCR & Engineered NK cell therapies 
  • Applications of gene therapy in clinical research 
  • Challenges from clinic to commercialization 
Day Two 
Gene Editing Technologies
  • Translating gene editing to the clinic 
  • Standardisation & quality control for gene editing 
Gene Therapy Analytics & CMC
  • Bioassays & analytical chemistry 
  • Developing advanced analytical characterization methods 
  • Tools to predict patient response to gene therapy 

Organized by: Oxford Global
Invited Speakers:

Donna McLaren - Vice President at Orchard Therapeutics

Nripen Singh - Director, Technical Development at PassageBio

Simon Briggs - Head of Gene Therapy Technical Product at Biogen

Lisa Kirkwood - Senior Expert Science & Technology at Novartis

Anthony Newcombe - Chief Operating Officer at VectorY

Elise Huang - Group Leader at UCB 

Deadline for Abstracts: 09/05/2023
Registration: Book Now - Gene Therapy Development 2023 (oxfordglobal.co.uk)
E-mail: h.liddiard@oxfordglobal.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.